⌕

Quest Diagnostics (DGX) vs Dexcom (DXCM)

Your goal
● Balanced style: every factor counts equally.
#1 FIT · LEADS
65
Quest Diagnostics, Inc.
$259.60 · $29B · as of last close
Best returnsCalmest rideBest income
of the stocks compared here

The front-runner. Leads the balanced score. Its widest win over the field is total return.

#2 FIT
47
Dexcom Inc
$83.33 · $31B · as of last close
Fastest growerStreet favoriteHighest quality
of the stocks compared here

The challenger. Trails the leader on the balanced score. Its widest win over the field is growth.

DGX leads clearly (65/100 vs DXCM 47) under a balanced style, mostly on total return. But DXCM wins on growth, so the comparison turns on what you weight. Switch your goal above and watch the scores move.

THE SCORECARD · FACTOR BY FACTOR · the best value in each row is ticked, and a tie ticks every tied column · weight bar shows how much it counts for your goal

FactorDGXDXCM
Overall fit score
weighted for your balanced goal
✓ 65
47
Valuation
Cheaper for what you get
1×
✓ P/E 26 · EV/EBITDA 14.6
P/E trailing
61
P/E 32 · EV/EBITDA 20.4
P/E trailing
39
Growth
Revenue & earnings momentum
1×
—
33
✓ —
68
Profitability & quality
Margins & return on capital
1×
Net 10% · ROIC 10%
TTM through Sep 30, 2026
62
✓ Net 19% · ROIC 25%
TTM through Sep 30, 2026
73
Total return
Share-price change with dividends reinvested
1×
✓ 5Y +15%/yr
78
5Y −33%/yr
3
Risk (calm = better)
Volatility & drawdown
1×
✓ β 0.2 · DD −29%
99
β 0.8 · DD −92%
39
Balance sheet†
Debt vs cash cushion
1×
Net debt/EBITDA 2.1×
TTM through Sep 30, 2026
33
✓ Net debt/EBITDA −0.4×
TTM through Sep 30, 2026
42
Dividend & income
Cash paid to you
1×
✓ 1.30% yield· A+
91
—
40
Analyst sentiment
Forward EPS growth (consensus)
1×
Est EPS +6%/yr · 11 analysts
59
✓ Est EPS +16%/yr · 15 analysts
74
† Balance sheet is scored on 5 peer percentiles (current ratio, quick ratio, net debt/EBITDA, interest coverage and debt/equity). The cell shows one of them, so a column can lead on the printed number and still lose the row.
The letter beside the dividend yield is our dividend-safety grade (A+ to F), a read on how likely that dividend is to be cut. It does not grade the yield.
Loading chart…
WHERE EACH ONE IS STRONG
GrowthValueQualityReturnSafetyIncome
■ DGX■ DXCM
CAN YOU STOMACH THE RIDE?
Worst drawdown3-year beta vs S&P 500VolatilityHistory
DGX−29%0.1723%5Y
DXCM−92%0.8158%5Y
Drawdown and volatility are measured over five years on the same total return as the chart, dividends reinvested.
THE CASE FOR & AGAINST EACH
BULL CASE

▲ Leads on total return: 5Y +15%/yr (score 78).

▲ Leads on risk (calm = better): β 0.2 · DD −29% (score 99).

BEAR CASE

▼ Weakest on growth: — (score 33).

▼ Weakest on analyst sentiment: Est EPS +6%/yr · 11 analysts (score 59).

BULL CASE

▲ Leads on growth: — (score 68).

▲ Leads on analyst sentiment: Est EPS +16%/yr · 15 analysts (score 74).

BEAR CASE

▼ Weakest on total return: 5Y −33%/yr (score 3).

▼ Weakest on risk (calm = better): β 0.8 · DD −92% (score 39).

WHAT COULD CHANGE THE SCORE
GrowthCurrently 33/100 (—). Taking it to 100 would lift the balanced score by 8 points, the biggest single move available.
Balance sheetCurrently 33/100 (Net debt/EBITDA 2.1×). Taking it to 100 would lift the balanced score by 8 points, the next biggest.
Total returnCurrently 3/100 (5Y −33%/yr). Taking it to 100 would lift the balanced score by 12 points, the biggest single move available.
ValuationCurrently 39/100 (P/E 32 · EV/EBITDA 20.4). Taking it to 100 would lift the balanced score by 8 points, the next biggest.
Scores are Tenet composites, 0–100, reweighted for your selected goal. Seven of the eight factors are sector percentiles; analyst sentiment is an absolute curve on forward EPS growth, capped at 100, so two very high-growth names can share the top score. Moat/durability is not scored (qualitative, not measurable). Comparison is decision-support, not a recommendation · past performance does not predict future returns · Not investment advice · prices are each company's own latest close, the newest here being Nov 13, 2026 · valuation, growth, quality and balance scores from the Nov 13, 2026 scoring run · analyst consensus, return, risk and income scores computed Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.